Fundraising Fox
/Companies
Sign in

MYnd Analytics

Aliso Viejo, US · Founded 2000 · Delaware corporation · 4 employees on LinkedIn · 1 known investors

Find your way into MYnd Analytics

Sign up to see every warm intro you have to MYnd Analytics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the MYnd Analytics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Telemynd is a mental healthcare platform that connects patients with licensed providers through a human-centered approach, prioritizing privacy and continuity of care while using technology to reduce administrative burden and improve access.

Digital HealthHealthtechMental Health

Founders & leadership

PB
Paul BuckExecutive
GCGeorge Carpenter
George CarpenterCEO2007–2019George Carpenter leads MYnd Analytics, which operates Telemynd, a mental healthcare platform connecting patients with licensed providers. He has previously built companies incorporating clinical data and machine learning algorithms, and invests in small molecule and diagnostics funds.
PHPatrick Herguth
Patrick HerguthCEOCEO at CNS Response

Board

ZM
Zachary McAdooBoard director
AS
Andrew SassineBoard director
JP
John PappajohnBoard director
MV
Michal VotrubaBoard director
WS
Walter SchindlerBoard director
GH
Geoffrey HarrisBoard director
RF
Robert FollmanBoard director
RS
Robin SmithBoard director
RT
Richard TurnerBoard director

Investors · 1

Funding

SEC filings, press & company announcements

$11.5M disclosed across 7 of 10 rounds · 2014–2023

  • Undisclosed amountprivate placementApr 2018
    Source ↗
▶$235KofferedJan 2023 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Ian ZwickerDirector
  • Charles StarkExecutive Officer
  • Yasushi NagasakiExecutive Officer
  • Wei Peu (Derek) ZenDirector
  • Willis LeeExecutive Officer, Director
  • George SekulichExecutive Officer
  • Yutaka NiiharaExecutive Officer, Director
  • Lim SeahDirector
Offering amount
$235K
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$34MofferedJan 2023 · 3 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Yasushi NagasakiExecutive Officer
  • Charles StarkExecutive Officer
  • Yutaka NiiharaExecutive Officer, Director
  • George SekulichExecutive Officer
  • Ian ZwickerDirector
  • Willis LeeExecutive Officer, Director
  • Lim SeahDirector
  • Wei Peu (Derek) ZenDirector
Offering amount
$34M
First sale
Jan 2023
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$110KraisedJun 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Yutaka NiiharaExecutive Officer, Director
  • Charles StarkExecutive Officer
  • Robert DickeyDirector
  • Masaharu OsatoDirector
  • George SekulichExecutive Officer
  • Yasushi NagasakiExecutive Officer
  • Wei Peu (Derek) ZenDirector
  • Willis LeeExecutive Officer, Director
Offering amount
$220K
Amount sold
$110K
Minimum investment
$110K
First sale
Jun 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.9MraisedFeb 2021 · 10 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Masaharu OsatoDirector
  • Wei Peu ZenDirector
  • Jane Pine WoodDirector
  • Ian ZwickerDirector
  • Yutaka NiiharaExecutive Officer, Director
  • Willis LeeExecutive Officer, Director
  • Yasushi NagasakiExecutive Officer
  • Robert DickeyDirector
Offering amount
$17M
Amount sold
$1.9M
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$3.8MraisedOct 2020 · 18 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Yutaka NiiharaExecutive Officer, Director
  • Ian ZwickerDirector
  • Jane Pine WoodDirector
  • Wei Peu ZenDirector
  • Masaharu OsatoDirector
  • Robert DickeyDirector
  • Joseph SherwoodExecutive Officer
  • Willis LeeExecutive Officer, Director
Offering amount
$3.8M
Amount sold
$3.8M
Finders' fees
$157.5K
Placement agents
T.R. Winston & Company LLC
First sale
Sep 2020
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$947.6KraisedAug 2020 · 18 investors · Pharmaceuticals
Rule 506(c)
Officers, directors & promoters on the filing
  • Joseph SherwoodExecutive Officer
  • Ian ZwickerDirector
  • Willis LeeExecutive Officer, Director
  • Masaharu OsatoDirector
  • Jane Pine WoodDirector
  • Yutaka NiiharaExecutive Officer, Director
  • Wei Peu ZenDirector
  • Robert DickeyDirector
Offering amount
$1.9M
Amount sold
$947.6K
First sale
Jul 2020
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗
▶$4MraisedJan 2016 · 15 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Geoffrey HarrisDirector
  • Paul BuckExecutive Officer
  • Zachary McAdooDirector
  • Robert FollmanDirector
  • Andrew SassineDirector
  • Robin SmithDirector
  • George CarpenterExecutive Officer
  • John PappajohnDirector
  • Michal VotrubaDirector
Offering amount
$6M
Amount sold
$4M
Minimum investment
$5K
Proceeds to insiders
$478K
First sale
Sep 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$260KraisedSep 2014 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • John PappajohnDirector
  • Paul BuckExecutive Officer
  • Zachary McAdooDirector
  • George CarpenterExecutive Officer
  • Thomas TierneyDirector
  • Walter SchindlerDirector
  • Richard TurnerDirector
  • Robert FollmanDirector
  • Andrew SassineDirector
Offering amount
$1M
Amount sold
$260K
Minimum investment
$5K
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does MYnd Analytics do?
Telemynd is a mental healthcare platform that connects patients with licensed providers through a human-centered approach, prioritizing privacy and continuity of care while using technology to reduce administrative burden and improve access.
Who are MYnd Analytics's investors?
MYnd Analytics's investors include BioBrit.
How much funding has MYnd Analytics raised?
MYnd Analytics has disclosed $11.5M raised across 7 of its 10 known rounds.
Where is MYnd Analytics headquartered?
MYnd Analytics is headquartered in Aliso Viejo, US.